← Browse by Condition
Medical Condition

recurrent disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05260671 Phase 2
Recruiting

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Enrollment
48 pts
Location
China
Sponsor
Eye & ENT Hospital of Fudan Un...
View Trial →